Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression

Research output: Contribution to journalArticlepeer-review

417 Scopus citations

Fingerprint Dive into the research topics of 'Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression'. Together they form a unique fingerprint.

Medicine & Life Sciences